AI

Today we delve into the dynamic world of clinical trials. This discussion aims to uncover the intricacies and challenges...

Merck KGaA, a renowned science and technology company, has announced the results of its two Phase III EVOLUTION clinical...

PsychoGenics Inc., with its drug discovery platform PGI Drug Discovery LLC, has announced an exclusive license agreement with Roche...

The 2023 CNS Summit featured a significant panel discussion on the future of clinical trials led by Isaac Galatzer-Levy,...

The 2023 CNS Summit featured a panel with Microsoft, marking a significant milestone in understanding AI in clinical trials....

The AI Bill of Rights, released by the White House, offers a comprehensive guide to ensuring AI’s ethical and...

During the recent SCOPE Summit Europe 2023, a remarkable session unfolded where Raul Castellanos Moreira, Rheumatology Medical Lead for...

The rapidly evolving field of artificial intelligence (AI) and data analytics offers immense potential for enhancing clinical trial quality...

Bristol Myers Squibb (BMS) has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review...

In today’s in-depth conversation, we delve into the evolving landscape of data management through EHR in clinical trials, focusing...